updated Sun. September 8, 2024
-
Post Analyst
February 2, 2018
Turning to Actinium Pharmaceuticals, Inc. (NYSE:ATNM), its shares were trading at $0.7 a retreat of $-0.01, on the trading floor. The stock, after opening at $0.71, touched a high of $0.73 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus callÃÂ ...
TrueBlueTribune
February 2, 2018
Actinium Pharmaceuticals Inc logo Zacks Investment Research upgraded shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) from a hold rating to a buy rating in a research report sent to investors on Tuesday, January 16th. They currently have $0.75 price target on the biotechnology company'sÃÂ ...
StockNewsTimes
February 1, 2018
Actinium Pharmaceuticals Inc logo Zacks Investment Research cut shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) from a buy rating to a hold rating in a research report sent to investors on Monday, January 15th. According to Zacks, “Actinium Pharmaceuticals, Inc. is a biopharmaceuticalÃÂ ...
StockNewsTimes
February 1, 2018
Actinium Pharmaceuticals Inc logo Zacks Investment Research upgraded shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) from a hold rating to a buy rating in a report released on Tuesday, January 16th. They currently have $0.75 price objective on the biotechnology company's stock.
Nelson Research
January 29, 2018
Penny stock investors are finding themselves looking closer at Actinium Pharmaceuticals, Inc. (:ATNM)'s shares due to the fact that the stock's price shifted -0.27%, reaching a price level of $0.75 after the conclusion of the recent trading day. Technical analysts have little regard for the value of a company.
Post Analyst
January 29, 2018
Turning to Actinium Pharmaceuticals, Inc. (NYSE:ATNM), its shares were trading at $0.75 a retreat of $0, on the trading floor. The stock, after opening at $0.75, touched a high of $0.76 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2ÃÂ ...
NASDAQ Times
January 29, 2018
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) belongs to Healthcare sector, except individual factors many other macro and micro factors also effects whole sector and industries. Shares eased up 0.09% to close at $0.75. Expecting these factors, the firm is standing on a contradictory position. To cut downÃÂ ...
BZ Weekly
January 29, 2018
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) institutional sentiment increased to 2 in 2017 Q3. Its up 0.71, from 1.29 in 2017Q2. The ratio is better, as 16 investment professionals opened new and increased stock positions, while 8 trimmed and sold stock positions in Actinium Pharmaceuticals Inc. TheÃÂ ...
Economic News
January 26, 2018
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) has seen its stock price gain 0.09, or +13.64%, so far in 2017. In the past 3-month period alone, shares of ATNM have appreciated -0.01 – or -1.32%. The stock's 52-week range is $0.54 to $1.72, and its 3-month range is $0.58 to $0.78. The average Wall StreetÃÂ ...
Searcy News
January 24, 2018
The Percentage Price Oscillator Histogram trend indicator is presently higher than zero on shares of Actinium Pharmaceuticals Inc (ATNM). Active traders may be carefully watching the indicator to see if the position is pointing to the stock as a buy. Technical traders often make a point of keeping an eye onÃÂ ...
Stock Press Daily
January 24, 2018
Actinium Pharmaceuticals Inc (ATNM) shares are moving today on volatility -0.67% or -0.0049 from the open. The NYSE listed company saw a recent bid of 0.73 and 103459 shares have traded hands in the session. Many individual investors would agree that self confidence can play a major role whenÃÂ ...
Nasdaq Journal
January 24, 2018
Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM) closed the previous trading session at $0.74, experiencing a change of -0.54% with 407,593 shares trading hands. The stock holds an average trading capacity of 772.38K shares for the past three months. When we compare its current volume withÃÂ ...
Concord Register
January 24, 2018
Investors seeking value in the stock market may be eyeing the Magic Formula Rank or MF Rank for Actinium Pharmaceuticals, Inc. (AMEX:ATNM). Presently, the company has a MF Rank of 18799. The Magic Formula was devised and made popular by Joel Greenblatt in his book “The Little Book That BeatsÃÂ ...
StockNewsTimes
January 24, 2018
According to Zacks, “Actinium Pharmaceuticals, Inc. is a biopharmaceutical company. It specializes in the development of cancer drugs. The company's principal product candidates under different developmental stages include Actimab-A for the treatment of acute myeloid leukemia in elderly patients andÃÂ ...
USMarketsDaily (blog)
January 23, 2018
Actinium is planning to launch the phase II study at 5 to 7 more sites including Canada in which the company has already received clearance to commence the study from the Health Canada organization. At the moment, there are no effective treatments for BMT approved by FDA and Actinium's lomab-B is likely to have aÃÂ ...
The Lincolnian Online
January 21, 2018
Actinium Pharmaceuticals logo Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) has been given a $3.00 target price by equities research analysts at B. Riley in a report released on Wednesday, December 27th. The firm currently has a “buy” rating on the biotechnology company's stock. B. Riley's priceÃÂ ...
Nasdaq
January 8, 2018
Chicago, IL - January 8, 2018 - Stocks in this week's article Western Digital Corporation WDC , Hecla Mining Company HL , Sphere 3D Corp. ANY , Actinium Pharmaceuticals Inc. ATNM and Southern National Bancorp of Virginia Inc. SONA . Beat the Market with Rising P/E Technique. Investors are wellÃÂ ...
StreetInsider.com
December 31, 1999
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or "the Company") announced today that it has issued a letter to investors providing a company update and outlook for 2018. The letter to investors is available on the Company's investor relations page of its websiteÃÂ ...
BangaloreWeekly
November 5, 2017
Actinium Pharmaceuticals (NYSE:ATNM) opened at 1.09 on Wednesday. The company has a 50-day moving average price of $1.14 and a ...
Dispatch Tribunal
November 4, 2017
Actinium Pharmaceuticals logo Actinium Pharmaceuticals Inc (NYSEMKT:ATNM)'s stock had its “buy” rating reiterated by stock analysts at ...
FactsReporter
November 2, 2017
Actinium Pharmaceuticals, Inc. (ATNM) belonging to the Healthcare sector has surged 3.54% and closed its last trading session at $0.65.
Financial Newsweek
October 30, 2017
Actinium Pharmaceuticals, Inc. (AMEX:ATNM) presently has a current ratio of 3.04. The current ratio, also known as the working capital ratio, ...
Stocks Gallery
October 27, 2017
In recent trading day Actinium Pharmaceuticals, Inc. (ATNM) stock showed the move of 4.05% with the closing price of $0.76. Closing price ...
AllStockNews
October 27, 2017
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) closed October 26 at $0.65, down -62.21% or $1.07 from its record high price of $1.72. Looking ...
Economic News
October 26, 2017
Over the last few days fluctuation in the stock of Actinium Pharmaceuticals, Inc. (NYSE:ATNM) was the main talking point of investors.
Baldwin Journal
October 25, 2017
Focusing in on the signals for Actinium Pharmaceuticals Inc (ATNM), we have recently seen that the Kaufman Adaptive Moving Average is ...
Union Trade Journal
October 25, 2017
Shares of Actinium Pharmaceuticals Inc (ATNM) are moving on volatility today 2.78% or 0.02 from the open. The NYSE listed company saw a recent bid of 0.74Â ...
Midway Monitor
October 25, 2017
Taking a look at the numbers, Actinium Pharmaceuticals Inc (ATNM) has a 14-day Commodity Channel Index (CCI) of 138.92. The CCIÂ ...
TrueBlueTribune
October 25, 2017
Actinium Pharmaceuticals Inc logo Roth Capital reiterated their buy rating on shares of Actinium Pharmaceuticals Inc (AMEX:ATNM) in a report ...
MTNV
October 25, 2017
Taking a look at some historical volatility numbers on shares of Actinium Pharmaceuticals, Inc. (AMEX:ATNM), we can see that the 12 month ...
DARC News
October 24, 2017
Actinium Pharmaceuticals Inc (ATNM) shares are on chartist's watch as the stock is edging above the MACD Histogram zero line. Current levels ...
USA Commerce Daily
October 24, 2017
Shares of Pebblebrook Hotel Trust (NYSE:PEB) are making a strong comeback as they have jumped 48.56% since bottoming out at $23.56 on ...
HuronReport
October 23, 2017
Among 2 analysts covering Actinum Pharma (NYSEMKT:ATNM), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Actinum ...
Stock Rover
October 23, 2017
Shares of Actinium Pharmaceuticals Inc (ATNM) have been trending lower over the past five bars, revealing bearish momentum for the shares, ...
MTNV
October 23, 2017
Shares of Actinium Pharmaceuticals Inc (ATNM) is moving on volatility today 3.45% or 0.025 from the open. The NYSE listed company saw a ...
Morgan Research
October 23, 2017
In recent trading action Actinium Pharmaceuticals, Inc. (:ATNM) stock moved -3.08% landing at $0.76. This stock has garnered attention of ...
Post Analyst
October 23, 2017
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) is on recovery track with 34.51% gain from a 1-year low price of $0.54. The company added ...
CML News
October 22, 2017
Price Alert: Actinium Pharmaceuticals Inc (AMEX:ATNM) has now crossed into technical strength -- watch the technical oscillators for ...
Post Analyst
October 16, 2017
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) is at least 36.55% than its current record low price of $0.54. There was a 7.45% gain on ...
Economic News
October 13, 2017
Cytori Therapeutics, Inc. (NASDAQ:CYTX) and Actinium Pharmaceuticals, Inc. (NASDAQ:ATNM) are both Healthcare companies that recently ...
StockNewsGazette
October 11, 2017
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) seems to be forming a pattern of major movements, providing only some crumbs of outlook for ...
Seeking Alpha
October 4, 2017
Nano cap Actinium Pharmaceuticals (NYSEMKT:ATNM) is up 10% premarket on robust volume in response to its continued advancement of a ...
Stocks Gallery
December 31, 1999
As close of recent trade, Actinium Pharmaceuticals, Inc. (ATNM) is standing at value of $0.64 with the falling stream of -4.48%. Active Investors ...
StockNewsJournal
December 31, 1999
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) ended its day at $0.76 with the rising stream of 4.05% and its total traded volume was 6.92Â ...
News Oracle
October 7, 2017
Actinium Pharmaceuticals, Inc. (ATNM) will report its next earnings on Nov 03 AMC. The company reported the earnings of $-0.12/Share in theÃÂ ...
JCTY News
October 7, 2017
Actinium Pharmaceuticals Inc (ATNM) shares are moving today on volatility -2.23% or $-0.016 from the open. The NYSE listed company saw aÃÂ ...
StockNewsJournal
October 7, 2017
Actinium Pharmaceuticals, Inc. (ATNM) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has beenÃÂ ...
StockNewsJournal
October 5, 2017
Actinium Pharmaceuticals, Inc. (ATNM) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has beenÃÂ ...
Stock Daily Review
September 9, 2017
Broadwind Energy, Inc. (NasdaqCM:BWEN) currently has a Value Composite score of 5. Similarly, the Value Composite Two (VC2) isÃÂ ...
Nelson Research
September 9, 2017
Reaching $0.66 after a recent trading day, shares of Actinium Pharmaceuticals, Inc. (:ATNM) have been making headlines in the micro capÃÂ ...
|
news and opinion
|
